1-3 of 3
P. J. Lugtenburg
Close
Sort by
Journal Articles

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

Clinical Trials & Observations
J. J. Eertink, G. J. C. Zwezerijnen, M. W. Heymans, S. Pieplenbosch, S. E. Wiegers, U. Dührsen, A. Hüttmann, L. Kurch, C. Hanoun, P. J. Lugtenburg, S. F. Barrington, N. G. Mikhaeel, L. Ceriani, E. Zucca, S. Czibor, T. Györke, M. E. D. Chamuleau, O. S. Hoekstra, H. C. W. de Vet, R. Boellaard, J. M. Zijlstra
Journal: Blood
Blood (2023) 141 (25): 3055–3064.
https://doi.org/10.1182/blood.2022018558
Published: 2023
Includes: Supplemental data
Journal Articles

The Position of MYC Rearrangements in the Genomic Landscape of Diffuse Large B-Cell Lymphoma

Erik Van Dijk, Jurriaan Janssen, Matias Mendeville, G. Tjitske Los-De Vries, Margaretha GM Roemer, Phylicia Stathi, Julia Richter, Yong Soo Kim, Wolfram Klapper, Ulrich Dührsen, Andreas Hüttmann, P. J Lugtenburg, Josée M. Zijlstra, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau, Bauke Ylstra
Journal: Blood
Blood (2022) 140 (Supplement 1): 9261–9263.
https://doi.org/10.1182/blood-2022-160052
Published: 2022
Journal Articles

Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands: a population-based study, 1989-2018

Clinical Trials & Observations
D. E. Issa, R. L. Seefat, O. Visser, S. Zweegman, P. J. Lugtenburg, A. G. Dinmohamed, M. E. D. Chamuleau
Journal: Blood
Blood (2021) 137 (20): 2848–2851.
https://doi.org/10.1182/blood.2020009552
Published: 2021
Includes: Supplemental data